Малта - Енглески - Medicines Authority

dali pharma gmbh brehmstrasse 56, 40239, dusseldorf,, germany - powder for solution for infusion or injection - ceftriaxone sodium 1500 mg - antibacterials for systemic use

Малта - Енглески - Medicines Authority

venus pharma gmbh am bahnhof 1-3, werne, d 59368, germany - concentrate for solution for infusion - docetaxel 20 mg/ml - antineoplastic agents

Малта - Енглески - Medicines Authority

venus pharma gmbh am bahnhof 1-3, werne, d 59368, germany - concentrate for solution for infusion - docetaxel 20 mg/ml - antineoplastic agents

Малта - Енглески - Medicines Authority

venus pharma gmbh am bahnhof 1-3, werne, d 59368, germany - concentrate for solution for infusion - docetaxel 20 mg/ml - antineoplastic agents

Ирска - Енглески - HPRA (Health Products Regulatory Authority)

krka, d.d., novo mesto - benzydamine hydrochloride; cetylpyridinium chloride - oromucosal spray, solution - 1.5 mg/ml+5.0 milligram(s)/millilitre - antiseptics; various - throat preparations, antiseptics - it is indicated in adults and children over 6 years of age for anti-inflammatory, analgesic and antiseptic treatment of irritations in the throat, mouth and gums, in gingivitis, pharyngitis and laryngitis and before and after tooth extractions

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

h.j. harkins company, inc. - fentanyl citrate (unii: mun5lyg46h) (fentanyl - unii:uf599785jz) - fentanyl 400 ug - oral transmucosal fentanyl citrate (otfc) is indicated only for the management of breakthrough cancer pain in patients 16 and older with malignancies who are already receiving and who are tolerant to around-the-clock opioid therapy for their underlying persistent cancer pain . patients considered opioid tolerant are those who are taking around-the-clock medicine consisting of at least 60 mg of oral morphine daily, at least 25 mcg of transdermal fentanyl/hour, at least 30 mg of oral oxycodone daily, at least 8 mg of oral hydromorphone daily or an equianalgesic dose of another opioid daily for a week or longer. patients must remain on around-the-clock opioids when taking otfc. this product must not be used in opioid non-tolerant patients because life-threatening respiratory depression and death could occur at any dose in patients not on a chronic regimen of opioids. for this reason, otfc is contraindicated in the management of acute or postoperative pain. otfc is intended to be used only in the care of cancer

Европска Унија - Енглески - EMA (European Medicines Agency)

abz-pharma gmbh - filgrastim - neutropenia; hematopoietic stem cell transplantation; cancer - colony stimulating factors - biograstim is indicated for the reduction in the duration of neutropenia and the incidence of febrile neutropenia in patients treated with established cytotoxic chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes) and for the reduction in the duration of neutropenia in patients undergoing myeloablative therapy followed by bone-marrow transplantation considered to be at increased risk of prolonged severe neutropenia. the safety and efficacy of filgrastim are similar in adults and children receiving cytotoxic chemotherapy.biograstim is indicated for the mobilisation of peripheral blood progenitor cells (pbpc).in patients, children or adults, with severe congenital, cyclic, or idiopathic neutropenia with an absolute neutrophil count (anc) of 0.5 x 109/l, and a history of severe or recurrent infections, long-term administration of biograstim is indicated to increase neutrophil counts and to reduce the incidence and duration of infection-related events.biograstim is indicated for the treatment of persistent neutropenia (anc less than or equal to 1.0 x 109/l) in patients with advanced hiv infection, in order to reduce the risk of bacterial infections when other options to manage neutropenia are inappropriate.

Ирска - Енглески - HPRA (Health Products Regulatory Authority)

orion corporation - detomidine hydrochloride - oromucosal gel - 7.6 milligram(s)/millilitre - detomidine - horses - neurological preparations

Ирска - Енглески - HPRA (Health Products Regulatory Authority)

sanofi-aventis ireland limited t/a sanofi - ambroxol hydrochloride - oromucosal spray, solution - 17.86 milligram(s)/millilitre - anesthetics, local

Малта - Енглески - Medicines Authority

aristo pharma gmbh wallenroder straße 8–10, 13435, berlin, germany - omeprazole - gastro-resistant capsule - omeprazole 10 mg - drugs for acid related disorders